Pharmacokinetic-pharmacodynamic modelling and simulation of methotrexate dosing in patients with rheumatoid arthritis.

Autor: Tan JM; University of South Australia (UniSA: Clinical and Health Sciences, Centre for Pharmaceutical Innovation), Adelaide, South Australia, Australia., Upton RN; Australian Centre for Pharmacometrics, University of South Australia, Adelaide, South Australia, Australia., Foster DJR; Clinical and Health Sciences, Australian Centre for Precision Health, University of South Australia, Adelaide, South Australia, Australia., Proudman SM; Royal Adelaide Hospital, Adelaide (South Australia), Australia. Discipline of Medicine, University of Adelaide, Adelaide, Australia., Dhir V; Clinical Immunology and Rheumatology Unit, Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Wiese MD; University of South Australia (UniSA: Clinical and Health Sciences, Centre for Pharmaceutical Innovation), Adelaide, South Australia, Australia.

Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Nov; Vol. 90 (11), pp. 2763-2780. Date of Electronic Publication: 2024 Jul 05.

Compliance with the guidelines for laboratory monitoring of patients treated with lithium: A retrospective follow-up study among ambulatory patients in the Netherlands.

Autor: Nederlof M; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Brocacef Ziekenhuisfarmacie, Maarssen, The Netherlands., Egberts TC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands., van Londen L; Transparant, Centre for Psychiatry, Leiden, The Netherlands.; Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands., de Rotte MC; SCAL Medical Diagnostics, Leiden, The Netherlands., Souverein PC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Herings RM; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, Netherlands., Heerdink ER; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.; Research Group Innovation of Pharmaceutical Care, University of Applied Sciences Utrecht, Utrecht, The Netherlands.

Publikováno v: Bipolar disorders [Bipolar Disord] 2019 Aug; Vol. 21 (5), pp. 419-427. Date of Electronic Publication: 2019 Jan 02.

Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.

Autor: van Dijkhuizen EH; Department of Paediatric Immunology, University Medical Centre Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands ; Pediatria II, Reumatologia, IRCCS G. Gaslini, Largo Gaslini 5, 16147 Genova, Italy., Bulatović Ćalasan M; Department of Paediatric Immunology, University Medical Centre Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands., Pluijm SM; Department of Paediatric Haemato-Oncology, Erasmus University Medical Centre Rotterdam, Sophia Children's Hospital, Rotterdam, The Netherlands., de Rotte MC; Department of Clinical Chemistry, Erasmus University Medical Centre Rotterdam, Rotterdam, The Netherlands., Vastert SJ; Department of Paediatric Immunology, University Medical Centre Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands., Kamphuis S; Department of Paediatric Rheumatology, Erasmus University Medical Centre Rotterdam, Sophia Children's Hospital, Rotterdam, The Netherlands., de Jonge R; Department of Clinical Chemistry, Erasmus University Medical Centre Rotterdam, Rotterdam, The Netherlands., Wulffraat NM; Department of Paediatric Immunology, University Medical Centre Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.

Publikováno v: Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2015 Feb 18; Vol. 13, pp. 5. Date of Electronic Publication: 2015 Feb 18 (Print Publication: 2015).

Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients.

Autor: Ćalasan MB; Department of Paediatric Immunology, University Medical Centre Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands., den Boer E; Department of Clinical Chemistry, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., de Rotte MC; Department of Clinical Chemistry, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Vastert SJ; Department of Paediatric Immunology, University Medical Centre Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands., Kamphuis S; Department of Paediatric Rheumatology, Erasmus University Medical Centre Rotterdam, Sophia Children's Hospital, Rotterdam, The Netherlands., de Jonge R; Department of Clinical Chemistry, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Wulffraat NM; Department of Paediatric Immunology, University Medical Centre Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2015 Feb; Vol. 74 (2), pp. 402-7. Date of Electronic Publication: 2013 Nov 28.

Determinants of erythrocyte methotrexate polyglutamate levels in rheumatoid arthritis.

Autor: den Boer E; From the Department of Clinical Chemistry; Department of Rheumatology; Department of Pediatric Hemato-Oncology; Erasmus University Medical Center, Rotterdam, the Netherlands.E. den Boer, MSc; M.C.J.F. de Rotte, PharmD; S.G. Heil, PhD; R. de Jonge, PhD, Department of Clinical Chemistry; J.M. Hazes, MD, PhD, Department of Rheumatology; S.M.F. Pluijm, PhD, Department of Pediatric Hemato-Oncology, Erasmus University Medical Center., de Rotte MC; From the Department of Clinical Chemistry; Department of Rheumatology; Department of Pediatric Hemato-Oncology; Erasmus University Medical Center, Rotterdam, the Netherlands.E. den Boer, MSc; M.C.J.F. de Rotte, PharmD; S.G. Heil, PhD; R. de Jonge, PhD, Department of Clinical Chemistry; J.M. Hazes, MD, PhD, Department of Rheumatology; S.M.F. Pluijm, PhD, Department of Pediatric Hemato-Oncology, Erasmus University Medical Center., Pluijm SM; From the Department of Clinical Chemistry; Department of Rheumatology; Department of Pediatric Hemato-Oncology; Erasmus University Medical Center, Rotterdam, the Netherlands.E. den Boer, MSc; M.C.J.F. de Rotte, PharmD; S.G. Heil, PhD; R. de Jonge, PhD, Department of Clinical Chemistry; J.M. Hazes, MD, PhD, Department of Rheumatology; S.M.F. Pluijm, PhD, Department of Pediatric Hemato-Oncology, Erasmus University Medical Center., Heil SG; From the Department of Clinical Chemistry; Department of Rheumatology; Department of Pediatric Hemato-Oncology; Erasmus University Medical Center, Rotterdam, the Netherlands.E. den Boer, MSc; M.C.J.F. de Rotte, PharmD; S.G. Heil, PhD; R. de Jonge, PhD, Department of Clinical Chemistry; J.M. Hazes, MD, PhD, Department of Rheumatology; S.M.F. Pluijm, PhD, Department of Pediatric Hemato-Oncology, Erasmus University Medical Center., Hazes JM; From the Department of Clinical Chemistry; Department of Rheumatology; Department of Pediatric Hemato-Oncology; Erasmus University Medical Center, Rotterdam, the Netherlands.E. den Boer, MSc; M.C.J.F. de Rotte, PharmD; S.G. Heil, PhD; R. de Jonge, PhD, Department of Clinical Chemistry; J.M. Hazes, MD, PhD, Department of Rheumatology; S.M.F. Pluijm, PhD, Department of Pediatric Hemato-Oncology, Erasmus University Medical Center., de Jonge R; From the Department of Clinical Chemistry; Department of Rheumatology; Department of Pediatric Hemato-Oncology; Erasmus University Medical Center, Rotterdam, the Netherlands.E. den Boer, MSc; M.C.J.F. de Rotte, PharmD; S.G. Heil, PhD; R. de Jonge, PhD, Department of Clinical Chemistry; J.M. Hazes, MD, PhD, Department of Rheumatology; S.M.F. Pluijm, PhD, Department of Pediatric Hemato-Oncology, Erasmus University Medical Center. r.dejonge@erasmusmc.nl.

Publikováno v: The Journal of rheumatology [J Rheumatol] 2014 Nov; Vol. 41 (11), pp. 2167-78. Date of Electronic Publication: 2014 Sep 15.